Special Issue "Hepatitis in Precision Medicine"
Deadline for manuscript submissions: closed (1 July 2023) | Viewed by 1142
Precision medicine is set to be the next generation of healthcare research and is an innovative approach to providing decisions about disease prevention, diagnostics, and treatment that takes into account differences in people's genes, environments, and lifestyles. The goal of this Special Issue “Hepatitis in Precision Medicine” is to target the best prevention, diagnostics, and treatment for each hepatitis patient. If possible, I would appreciate receiving your submission by 1 July 2023. If you already have a manuscript ready for publication, I would appreciate your submission at your earliest convenience.
Looking forward to your response.
Dr. Zheng Zeng
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- clinical trial